ESC 365 - Introduction.

Open Access

Introduction.

Session: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Topic: Drug therapy

Speaker: Professor P. Libby (Boston, US)

Organised by PACE-CME, supported by Amarin in the form of an educational grant

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

37 presentations

7 followers

4 more presentations in this session

The residual risk challenge in CVD: How important are triglycerides?

Speaker: Professor U. Landmesser (Berlin, DE)

Non-LDL in CV risk management & guidelines: What are the opportunities?

Speaker: Professor K. Ray (London, GB)

Lessons from REDUCE-IT: How will the results impact practice?

Speaker: Professor D. Bhatt (New York, US)

Discussion.

Speaker: Professor P. Libby (Boston, US)

Access the full session

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Speakers: Professor P. Libby, Professor U. Landmesser, Professor K. Ray, Professor D. Bhatt, Professor P. Libby

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources